- Home
- AXIL vs NTRB Comparison
AXIL vs NTRB Comparison
Compare AXIL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXIL | NTRB |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Package Goods/Cosmetics | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 54.1M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | AXIL | NTRB |
|---|---|---|
| Price | $7.09 | $3.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.8K | ★ 12.8K |
| Earning Date | 04-10-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $26,257,522.00 | N/A |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $53.85 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.04 | $3.42 |
| 52 Week High | $10.25 | $11.68 |
Technical Indicators
Market Signals| Indicator | AXIL | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 60.39 | 36.79 |
| Support Level | $4.76 | $3.53 |
| Resistance Level | $7.35 | $4.50 |
| Average True Range (ATR) | 0.36 | 0.28 |
| MACD | 0.14 | -0.02 |
| Stochastic Oscillator | 88.10 | 15.25 |
Price Performance
Historical ComparisonAbout AXIL AXIL Brands Inc.
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.